Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis.
Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis.
复制标题
DOI:
10.1093/rheumatology/keaa789
复制
发表时间:
2021-07-01
期刊:
影响因子:
--
通讯作者:
Nurmohamed MT
中科院分区:
文献类型:
--
作者:
Agca R;Blanken AB;van Sijl AM;Smulders YM;Voskuyl AE;van der Laken C;Boellaard R;Nurmohamed MT
RA is associated with higher risk of cardiovascular (CV) disease. Ongoing systemic inflammation is presumed to accelerate atherosclerosis by increasing inflammation in the arterial wall. However, evidence supporting this hypothesis is limited. We aimed to investigate arterial wall inflammation in RA vs OA, and its association with markers of inflammation and CV risk factors. 18-fluorodeoxyglucose PET combined with CT (18F-FDG-PET/CT) was performed in RA (n = 61) and OA (n = 28) to investigate inflammatory activity in the wall of large arteries. Secondary analyses were performed in patients with early untreated RA (n = 30), and established RA, active under DMARD treatment (n = 31) vs OA. Patients with RA had significantly higher 18F-FDG uptake in the wall of the carotid arteries (beta 0.27, 95%CI 0.11—0.44, P <0.01) and the aorta (beta 0.47, 95%CI 0.17—0.76, P <0.01) when compared with OA, which persisted after adjustment for traditional CV risk factors. Patients with early RA had the highest 18F-FDG uptake, followed by patients with established RA and OA respectively. Higher ESR and DAS of 28 joints values were associated with higher 18F-FDG uptake in all arterial segments. Patients with RA have increased 18F-FDG uptake in the arterial wall compared with patients with OA, as a possible marker of early atherosclerosis. Furthermore, a higher level of clinical disease activity and circulating inflammatory markers was associated with higher arterial 18F-FDG uptake, which may support a role of arterial wall inflammation in the pathogenesis of vascular complications in patients with RA.
登录
查看更多内容
影响因子:
4.7
作者:
Curtis, Jeffrey R.;Yang, Shuo;Zhang, Jie
通讯作者:
Zhang, Jie
影响因子:
3.1
作者:
Buesing, Karen A.;Schoenberg, Stefan O.;Wasser, Klaus
通讯作者:
Wasser, Klaus
影响因子:
2.6
作者:
Ozguven, Mehmet A.;Karacalioglu, Alper O.;Emer, Mustafa O.
通讯作者:
Emer, Mustafa O.
影响因子:
4.9
作者:
Bernelot Moens SJ;van der Valk FM;Strang AC;Kroon J;Smits LP;Kneepkens EL;Verberne HJ;van Buul JD;Nurmohamed MT;Stroes ES
通讯作者:
Stroes ES
影响因子:
2.4
作者:
Johnsrud, Kjersti;Skagen, Karolina;Revheim, Mona-Elisabeth
通讯作者:
Revheim, Mona-Elisabeth